Boosters cut long COVID risk significantly

Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.

Icon acquires HumanFirst to boost support for digital tools in clinical trials

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research

February 29, 2024

Lifelong low LDL-C levels key to preventing cardiovascular disease

Research shows maintaining low LDL-C levels over time reduces plaque buildup and lowers ASCVD risk by slowing atherosclerosis progression.

July 9, 2024

DEA Psilocybin Stance Critiqued by Federal Appeals Court

The TDR Three Key Takeaways: A federal appeals court has criticized the DEA for not adequately explaining its refusal to reclassify psilocybin, highlighting a need

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.